NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

You don't understand the difference between "failure" and "futility".

To all intents and purposes they amount to the same thing here.

Any DMC that understands immunotherapy response kinetics (likelihood of pseudo-progression, delayed treatment response, long-tail survival) would be very unlikely to deem this trial either futile or a failure at an early interim stage, where the median data was far from being reached.

And if AF knew anything about immunotherapy, he would also know this to be the case.

He might know this, but it doesn't fit his narrative!